Congleton Jon sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 for −$1.91M on Sep 30, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,909,665Shares × reported price
Shares traded
75,000Common Stock
Price per share
$25.46Reported price. Read footnotes for ranges.
% of reported position traded
12.43%This security and ownership context
Holdings after
528,621Direct
Trade date
Sep 30, 2026Sell
Filed
Oct 2, 2026, 5:53 PM ET2-day reporting delay
Accession
0001933414-26-000121Code S · Transaction 235654
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 603,621 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MLYS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MLYS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +8.6%1w ago +14%1d ago +3.6%
Returns since7d −1.1%30d −23%90d180d1y

Footnotes in full

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025. F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.8201. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.